Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
/
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Cemat A/S is a Denmark-based holding company listed on the NASDAQ Nordic stock exchange in Copenhagen, specializing in the real estate sector with primary operations in Warsaw, Poland. It operates through two key segments: Property Management, which focuses on leasing premises and land including small business units, self-storage facilities like CematBox, and office spaces, while providing essential utilities such as power, water, and facility services to tenants; and Property Development, involving the planning, construction, and sales of residential and commercial properties, highlighted by the Moje Bielany project that includes apartments and retail units. Cemat A/S owns a mixed-use logistics complex in Warsaw's Bielany district, maintains a landbank for future developments, and employs 19 staff headquartered in Copenhagen. Its 2024-2027 strategy emphasizes optimizing rental income through flexible warehousing, securing pre-sales to reduce risks, and pursuing organic growth via planning permissions and new investments, with the majority of revenue generated from Poland-based activities, positioning it as a contributor to sustainable, community-focused real estate in Europe.
DKK 0.09
DKK 0.00 (-0.22%)
EOD Jul 1, 2026
24.23% operating margin is above average. ROIC at 12.02%.
Revenue up 318.0% YoY with margins expanding 5.8pp.
Even for strong businesses, today's 0x P/E means the stock needs to keep delivering. There's no margin of safety if growth disappoints.
0.4x earnings, 0.5x FCF. The multiple is below average. Either the market is pricing in deterioration you should investigate, or there's genuine value here.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
DKK 165M
▲ +318.0% YoY
Net Income (TTM)
DKK 66M
▲ +389.7% YoY
Op. Margin
24.23%
▲ +5.8pp YoY
ROIC
12.02%
▲ +9.5pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
DKK 49M
▲ +476.2% YoY
Op. Cash Flow (TTM)
DKK 49M
▲ +537.4% YoY
Net Debt
-DKK 14M
Net Cash Position
Cash & Equiv.
DKK 40M
3Y CAGR: +83.7%
Continue Research
At a P/E of 0.4 and a price-to-free-cash-flow of 0.5, Cemat A/S (CEMAT.XCSE) trades below a two-stage DCF intrinsic value of about DKK 9.99 per share, so at DKK 0.09 the stock looks undervalued (10,755.2% below estimated intrinsic value). A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.
On quality, Cemat A/S scores 94/100 on Intrinsiqq's quality scorecard (a high-quality business on these measures), weighing growth, margins, returns on capital, share count, and balance-sheet strength. All figures are computed from SEC filings; read the full methodology. This is analysis, not investment advice.
Intrinsiqq's two-stage DCF estimates an intrinsic value of about DKK 9.99 per share for CEMAT.XCSE, projecting its recent free cash flow forward with a growth rate that fades toward a long-run rate and discounting it back to today. Applying a 25% margin of safety gives a more conservative fair-value entry around DKK 7.49. At today's DKK 0.09, that puts the stock about 10,755.2% below estimated intrinsic value. The result is sensitive to the growth and discount-rate inputs, so it is best to run conservative, base and optimistic cases. You can adjust all of them yourself with the sliders on the DCF tab.
Cemat A/S scores 94 out of 100 on Intrinsiqq's quality score, a weighted blend of 8 metrics each scored 0 to 100, which makes it a high-quality business on these measures. Recent fundamentals include a 24.2% operating margin and a 12.0% return on invested capital. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from SEC filings, not opinion. Because valuation only means something relative to quality, the full metric-by-metric breakdown is on the quality scorecard.
That depends on valuation and quality together, not either alone. CEMAT.XCSE currently trades below its estimated intrinsic value and scores 94/100 on quality (high-quality). A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from SEC filings, not investment advice.